The Traveler-based Genomic Surveillance program, led by CDC’s Travelers’ Health Branch, was introduced during the Covid-19 pandemic to detect new SARS-CoV-2 variants and other pathogens through nasal swab and wastewater sample collection from arriving international travelers at US airports. “We have known that travelers are a very important population to consider for tracking new and emerging infections,” Dr.
Since the program’s inception, the agency has worked alongside Ginkgo Bioworks, a biotech company focused on building a global biosecurity infrastructure to empower governments, communities, and public health leaders to prevent, detect, and respond to a wide variety of biological threats.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: KIRO7Seattle - 🏆 271. / 63 Read more »